Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)

ClinicalTrials.gov ID: NCT00104273

Public ClinicalTrials.gov record NCT00104273. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 3:18 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 1-Year, Double-Blind, Randomized, Placebo-Controlled, Study of Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Dementia of the Alzheimer's Type

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety, tolerability, and efficacy of two dose levels of rasagiline mesylate versus placebo in patients with mild-to-moderate Alzheimer's Disease who are taking Aricept.

Study identification

NCT ID
NCT00104273
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
376 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
45 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2004 (Type not available)
Primary completion
Mar 2007 (Actual)
Completion
Not listed
Last update posted
Jul 15, 2009

Started 2004

United States locations

U.S. sites
31
U.S. states
21
U.S. cities
27
Facility City State ZIP Site status
Collaborative Neuroscience Network Huntsville Alabama 35801 —
North Alabama Neuroscience Research Huntsville Alabama 35801 —
Northwest Neurospecialists, PLLC Tucson Arizona 85741-3537 —
Clinical Study Centers, LLC Little Rock Arkansas 72205 —
East Bay Region Associates in Neurology Berkeley California 94705 —
Margolin Brain Institute Fresno California 93720 —
Collaborative Neuroscience Network Garden Grove California 92845 —
San Francisco Clinical Research Center San Francisco California 94109 —
Neurological Research Institute Santa Monica California 90404 —
University of Colorado Health Sciences Center Denver Colorado 80262 —
Premiere Research Institute West Palm Beach Florida 33407 —
North Broward Medical Center/Memory Disorder Center West Palm Beach Florida 33409 —
Emory University Wesley Woods Health Center Altanta Georgia 30329 —
Dekalb Neurology Associates, LLC Decatur Georgia 30033 —
Radiant Research Chicago Illinois 60610 —
Fort Wayne Neurological Center Fort Wayne Indiana 46805 —
Mid America Neuroscience Institute Lenexa Kansas 66214 —
Four Rivers Clinical Research Paducah Kentucky 42003 —
Tulane University Health Sciences Center, Dept of Psychiatry and Neurology New Orleans Louisiana 70112 —
Department of Neurology - Brigham and Women's Hospital Boston Massachusetts 02115 —
Northern Michigan Neurology Traverse City Michigan 49684 —
University Behavioral Healthcare Centre Department of Psychiatry Piscataway New Jersey 08854 —
Odyssey Research Fargo North Dakota 58104 —
Ohio State University, Department of Neurology Columbus Ohio 43210 —
Pahl Brain Associates Oklahoma City Oklahoma 73118 —
Medical University of South Carolina Alzheimer's Research and Clinical Programs North Charleston South Carolina 29406-6076 —
Department of Neurology Baylor College of Medicine Houston Texas 77030-2744 —
Premiere Research Institute Houston Texas 77030 —
University of Texas Mental Sciences Institute Houston Texas 77030 —
Peninsula Internal Medicine Associates Gig Harbor Washington 98335 —
Internal Medicine Northwest Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00104273, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 15, 2009 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00104273 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →